CADTH is partnering with Choosing Wisely Canada to identify actions that could lead to better post-pandemic care for Canadians. The organizations are developing recommendations for reducing low-value care that, if implemented, could make more resources available to deliver the priority services that are most beneficial to patients.
Throughout the COVID-19 pandemic, the effects of delayed non-urgent care and elective procedures have been a top concern of patients, health care professionals, and policy-makers. As health systems begin to reopen, tackling the issue of low value care — the tests and treatments that offer little benefit to patients and can waste health system resources — is important to help ensure patients receive high quality and necessary care.
Choosing Wisely Canada is reviewing its existing evidence-based recommendations with clinician experts and curating an initial shortlist of low-value treatments. Recommendations about tests and treatments will be considered to be included on the shortlist if they are:
- common in clinical practice, can cause harm, relatively frequent, and resource intensive
- associated with an area of need delayed by the pandemic or where there is an existing backlog
- a potential strain on health care human resources and system capacity
- aligned with categories of overuse identified by Choosing Wisely Canada and the Canadian Institute for Health Information
CADTH will then convene a panel of Canadian clinician, patient, and policy experts to review the shortlist and develop final recommendations for clinicians and senior policy decision-makers.
The results of this work will be presented at Choosing Wisely Canada’s National Meeting in May 2021 and will be published in CADTH’s Canadian Journal of Health Technologies.